Circulation, Vol 57, 314-320, Copyright © 1978 by American Heart Association
JS Borer, SL Bacharach, MV Green, KM Kent, GS Johnston and SE Epstein
The effects of nitroglycerin (TNG) on exercise-induced abnormalities of
left ventricular wall motion and ejection fraction are unknown in
symptomatic and asymptomatic patients with coronary artery disease (CAD).
In the present investigation radionuclide cineangiographic studies were
performed in 47 patients with CAD (14 without angina during exercise) and
in 25 normal subjects. All CAD patients, including those without symptoms,
demonstrated regional wall motion abnormalities during exercise. In all
patients, ejection fraction (EF) also responded abnormally to exercise: EF
decreased from 48% at rest to 36% during exercise (P less than 0.001). EF
increased in all normal subjects from an average of 58% at rest to 71%
during exercise (P less than 0.001). In all CAD patients TNG reduced
exercise-induced regional wall abnormalities and increased EF attained
during exercise from an average of 36 to 48% (P less than 0.001). EF in
normal subjects was unchanged by TNG. Thus, exercise can cause
abnormalities in left ventricular regional function and ejection fraction
in patients with or without symptoms; these abnormalities can be mitigated
by prophylactic TNG.
ARTICLES
Effect of nitroglycerin on exercise-induced abnormalities of left ventricular regional function and ejection fraction in coronary artery disease. Assessment by radionuclide clineagiography in symptomatic and asymptomatic patients
This article has been cited by other articles:
![]() |
G. I.W. Galasko and A. Lahiri The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques Eur J Heart Fail, June 1, 2003; 5(3): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. He, R. Medrano, J. T. Hays, J. J. Mahmarian, and M. S. Verani Nitroglycerin-Augmented 201Tl Reinjection Enhances Detection of Reversible Myocardial Hypoperfusion : A Randomized, Double-Blind, Parallel, Placebo-Controlled Trial Circulation, April 1, 1997; 95(7): 1799 - 1805. [Abstract] [Full Text] |
||||
![]() |
M.G. Niemeyer, E.E. van der Wall, A.F.M. Kuijper, A.T. Cleophas, and E.K.J. Pauwels Nuclear Cardiology, Current Applications in Clinical Practice Angiology, July 1, 1995; 46(7): 591 - 602. [Abstract] [PDF] |
||||
![]() |
A. ROZANSKI, G. A. DIAMOND, J. S. FORRESTER, D. S. BERMAN, D. MORRIS, and H. J. C. SWAN Alternative Referent Standards for Cardiac Normality: Implications for Diagnostic Testing Ann Intern Med, August 1, 1984; 101(2): 164 - 171. [Abstract] [PDF] |
||||
![]() |
D. W. Winsor, T. Winsor, B. G. Krohn, and J. R. Bernett Pharmacologic Effects of a Nitrate Coronary Vasodilator on Cardiac Perfusion and Function, Measured Semiquantitatively Angiology, September 1, 1982; 33(9): 617 - 624. [Abstract] [PDF] |
||||
![]() |
M. L. Lecklitner and M. L. Nusynowitz Nuclear Medicine: The Internist's View JAMA, June 5, 1981; 245(21): 2202 - 2203. [Abstract] [PDF] |
||||
![]() |
K. I. SHINE, J. K. PERLOFF, J. S. CHILD, R. C. MARSHALL, and H. SCHELBERT Noninvasive Assessment of Myocardial Function Ann Intern Med, January 1, 1980; 92(1): 78 - 90. [Abstract] [PDF] |
||||
![]() |
A. W. NIENHUIS, E. J. BENZ Jr., R. PROPPER, L. CORASH, W. F. ANDERSON, W. HENRY, and J. BORER Thalassemia Major: Molecular and Clinical Aspects Ann Intern Med, December 1, 1979; 91(6): 883 - 897. [Abstract] [PDF] |
||||
![]() |
S. E. Epstein, L. H. Gerber, and J. S. Borer Chest Wall Syndrome: A Common Cause of Unexplained Cardiac Pain JAMA, June 29, 1979; 241(26): 2793 - 2797. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1978 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |